| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.5 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.036 | 0.5 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.036 | 0.5 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |